Selecting the Components for a Safe and Efficient Tuberculosis Subunit Vaccine - Recent Progress and Post-Genomic Insights

Author(s): Limei Meng Okkels, T. Mark Doherty, Peter Andersen

Journal Name: Current Pharmaceutical Biotechnology

Volume 4 , Issue 1 , 2003

Become EABM
Become Reviewer
Call for Editor


Prophylactic vaccination against tuberculosis with BCG gained much of the credit for the decline of TB in Europe. However, with TB resurgent in many parts of the world, better vaccines are urgently needed. To improve on BCG, a rapid, rational approach to vaccine discovery is needed. Fortunately, advances in the fields of molecular biology and computer science have spawned new disciplines: Genomics, Proteomics and Transcriptomics are transforming the ways in which candidate vaccine antigens are discovered. In this review, we discuss how these new approaches have accelerated the pace of antigen discovery and vaccine development, and highlight some of the most promising new candidate vaccines and vaccine targets.

Keywords: tb vaccine, tuberculosis vaccine, tb resurgent, tuberculosis, calmette-guerin, bcg

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2003
Page: [69 - 83]
Pages: 15
DOI: 10.2174/1389201033377931

Article Metrics

PDF: 16